Schrödinger, Inc. (SDGR)


-0.86 (-3.44%)
Symbol SDGR
Price $24.12
Beta 1.165
Volume Avg. 0.57M
Market Cap 1.717B
Shares () -
52 Week Range 20.71-59.87
1y Target Est -
DCF Unlevered SDGR DCF ->
DCF Levered SDGR LDCF ->
ROE -27.37% Sell
ROA -21.49% Sell
Operating Margin -
Debt / Equity 39.51% Neutral
P/E -
P/B 3.48 Strong Buy


Consensus EPS

Upgrades & Downgrades

Latest SDGR news

Dr. Ramy Farid
Health Information Services
NASDAQ Global Select

Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.